Hennion & Walsh Asset Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.35 Billion
- Q2 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 2,253 shares of REGN stock, worth $1.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,253
Previous 2,343
3.84%
Holding current value
$1.3 Million
Previous $1.49 Million
20.46%
% of portfolio
0.05%
Previous 0.07%
Shares
18 transactions
Others Institutions Holding REGN
# of Institutions
1,423Shares Held
88.8MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.44 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.87 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.26 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.79 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.21 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $61.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...